Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE.

JAMA. 2007 Feb 7;297(5):499-508.

PMID:
17284700
2.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
3.

HDL-C: role as a risk modifier.

Barter P.

Atheroscler Suppl. 2011 Nov;12(3):267-70. doi: 10.1016/S1567-5688(11)70885-6. Review.

PMID:
22152280
4.

Effects on coronary atherosclerosis by targeting low-density lipoprotein cholesterol with statins.

Ferrières J.

Am J Cardiovasc Drugs. 2009;9(2):109-15. doi: 10.2165/00129784-200909020-00005. Review.

PMID:
19331439
5.

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Cziraky MJ, Watson KE, Talbert RL.

J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.

PMID:
19891279
6.

High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus.

Athyros VG, Katsiki N, Karagiannis A, Mikhailidis DP.

J Diabetes Complications. 2015 Jan-Feb;29(1):142-5. doi: 10.1016/j.jdiacomp.2014.10.004. Epub 2014 Oct 13. Review.

PMID:
25456820
7.

Effect of statin therapy on the progression of coronary atherosclerosis.

Tian J, Gu X, Sun Y, Ban X, Xiao Y, Hu S, Yu B.

BMC Cardiovasc Disord. 2012 Sep 1;12:70. doi: 10.1186/1471-2261-12-70. Review.

9.

Candidate mechanisms for regression of coronary atherosclerosis with high-dose statins: insight from intravascular ultrasonography trials.

Sipahi I, Tuzcu EM.

Am J Cardiovasc Drugs. 2008;8(6):365-71. doi: 10.2165/0129784-200808060-00003. Review.

PMID:
19159123
10.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401. Review.

PMID:
18480348
11.

Optimal therapy of low levels of high density lipoprotein-cholesterol.

Kashyap ML, Tavintharan S, Kamanna VS.

Am J Cardiovasc Drugs. 2003;3(1):53-65. Review.

PMID:
14727946
12.

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.

Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P, Pedersen TR, LaRosa JC, Waters DD, DeMicco DA, Simes RJ, Keech AC, Colquhoun D, Hitman GA, Betteridge DJ, Clearfield MB, Downs JR, Colhoun HM, Gotto AM Jr, Ridker PM, Grundy SM, Kastelein JJ.

J Am Coll Cardiol. 2014 Aug 5;64(5):485-94. doi: 10.1016/j.jacc.2014.02.615. Review.

13.

Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound.

Gao WQ, Feng QZ, Li YF, Li YX, Huang Y, Chen YM, Yang B, Lu CY.

BMC Cardiovasc Disord. 2014 May 2;14:60. doi: 10.1186/1471-2261-14-60. Review.

14.

Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trials.

de Faire U, Ericsson CG, Grip L, Nilsson J, Svane B, Hamsten A.

Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:257-63. Review.

PMID:
9211018
15.
16.

Coronary atherosclerosis can regress with very intensive statin therapy.

Sipahi I, Nicholls SJ, Tuzcu EM, Nissen SE.

Cleve Clin J Med. 2006 Oct;73(10):937-44. Review.

PMID:
17044319
17.

The effect of statin therapy on plaque regression following acute coronary syndrome: a meta-analysis of prospective trials.

Tang X, Yang Y, Luo S, Zhao Y, Lu C, Luo Y, Zhang F, Xiao H.

Coron Artery Dis. 2016 Dec;27(8):636-649. Review.

PMID:
27388482
18.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Postgrad Med J. 2008 Nov;84(997):590-8. doi: 10.1136/hrt.2007.125401. Review.

PMID:
19103817
19.

Association between LDL-C, Non HDL-C, and Apolipoprotein B Levels with Coronary Plaque Regression.

Masson W, Siniawski D, Lobo M, Molinero G, Giorgi M, Huerín M.

Arq Bras Cardiol. 2015 Jul;105(1):11-9. doi: 10.5935/abc.20150050. Epub 2015 May 19. Review. English, Portuguese.

20.

Regression of coronary atheroma with statin therapy.

Elshazly MB, Stegman B, Puri R.

Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):131-7. doi: 10.1097/MED.0000000000000234. Review.

PMID:
26910274

Supplemental Content

Support Center